Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | [212Pb]VMT01 |
Synonyms | |
Therapy Description |
[212Pb]VMT01 is a radioconjugate comprising the radionuclide 212Pb linked to a peptide targeting melanocortin 1 receptor (MC1R), which delivers radiation to MC1R-expressing tumor cells, potentially resulting in decreased tumor growth (PMID: 34359580). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
[212Pb]VMT01 | VMT01 | [212Pb]VMT01 is a radioconjugate comprising the radionuclide 212Pb linked to a peptide targeting melanocortin 1 receptor (MC1R), which delivers radiation to MC1R-expressing tumor cells, potentially resulting in decreased tumor growth (PMID: 34359580). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05636618 | Phase Ib/II | [212Pb]VMT01 | Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors ([212-Pb]-VMT) | Recruiting | USA | 0 |
NCT05655312 | Phase Ib/II | [212Pb]VMT01 | MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma | Recruiting | USA | 0 |